研究グレードタンパク質の市場規模、シェア、動向分析レポート：製品別、宿主細胞別、最終用途別、地域別、セグメント別予測、2023年～2030年

研究グレードタンパク質市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の研究グレードタンパク質市場規模は2030年までに26億9,000万米ドルに達し、2023年から2030年までのCAGRは15.53％で成長すると推定されています。

がん研究分野での研究開発投資の増加や個別化医薬品に対する需要の高まりが、市場の成長に寄与すると予測されています。また、様々な臨床研究のために多くの国で政府投資が増加しており、市場の成長を促進すると予想されています。さらに、新興諸国におけるバイオテクノロジー産業の進歩の高まりが、予測期間における市場の成長をさらに促進しています。

COVID-19パンデミックは、ワクチン、診断薬、治療薬開発のための研究活動の急増により、市場にプラスの影響を与えました。規制当局がワクチン候補の承認プロセスを迅速化することに注力したため、受託製造の需要が増加しました。mRNAワクチンのような新規ワクチンプラットフォームは大きな注目を集めたが、組み換えタンパク質ワクチンの代替品もいくつか評価されています。例えば、2022年7月、ノババックス社のCOVID-19ワクチン（NVX-CoV2373）は、EUで使用するための拡大条件付き製造販売承認を取得しました。さらに、パンデミックは、生物製剤における機敏で柔軟な製造能力の必要性を浮き彫りにしました。この要因は、競合情勢を後押しし、近い将来の市場成長を促進すると予想されます。

Global Genesによると、2019年10月、世界では4億人以上の人々が希少疾患や遺伝病を抱えて生活しています。この数字は、治療法および臨床設定の改善だけでなく、健康意識の切実な必要性を示しています。先進的な研究と薬剤標的メカニズムの知識が必要であることは、医薬品開発にとって極めて重要です。多くの地域では、コホート・プログラムからバイオバンクを開発し、研究者に高品質のサンプルを提供することで、治療への取り組みに革命をもたらしています。その結果、様々な疾患に対するバイオマーカー探索への注目が高まると予想されます。このように、より良いヘルスケアインフラを構築するための研究活動への取り組みや政府の関心は、研究グレードタンパク質の応用を強化し、結果として市場の成長を促進すると予想されます。

しかし、タンパク質の生産は時間のかかる作業であり、その過程で作業条件の高い維持管理が必要となることも多いです。これらの組換え製品に対する需要が高く、増え続けているにもかかわらず、規制機関からの支援はまだゆっくりとしたペースで進展しています。研究グレードタンパク質は通常、宿主または発現系を介して製造され、目的の製品に特異的な遺伝子が、トランスフェクション、細菌形質転換またはウイルス導入の段階を経て発現されます。この複雑な工程は、しばしば標的でない領域の過剰発現という欠点があり、さらに多くの時間を要します。このように、組換え技術に関する特定のガイドラインや規制がないことが、研究グレードタンパク質市場の活況を妨げる大きな要因となっています。

研究グレードタンパク質市場レポートハイライト

• 製品別では、サイトカイン＆成長因子分野が2022年に23.36％の最大収益シェアで市場を独占し、同分野は予測期間中に17.62％の最速CAGRで成長すると予測されています。これは、創薬および薬剤開発のためのさまざまな臨床試験における役割に起因しています。
• 宿主細胞に基づくと、哺乳類細胞セグメントは2022年に55.73%の最大収益シェアで市場を独占しました。この大きなシェアは、主にヒト細胞と生物学的構造が似ているためで、モノクローナル抗体、ワクチンなどのバイオ医薬品の生産に役立っています。
• 最終用途別では、製薬・バイオテクノロジー企業が2022年に61.35%の最大シェアを占めました。創薬開発のための研究活動の増加や個別化医薬品の需要の増加により、研究グレードタンパク質の需要は予測期間中に増加すると予測されています。
• 地域別では、北米が2022年の売上高シェア44.86%で市場を独占しています。この大きなシェアは、大手市場プレイヤーの存在と強固なヘルスケアインフラに起因しています。これらの要因は、予測期間中に同地域の研究グレードタンパク質市場を押し上げると予測されています。

目次

第1章 研究グレードタンパク質市場：調査手法と範囲

第2章 研究グレードタンパク質市場：エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 研究グレードタンパク質市場変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場動向と展望
• 市場力学
  • 研究活動における組換えタンパク質の使用の増加
  • 創薬と精密医療のための調査活動の拡大
  • 生物製剤およびバイオシミラーの採用の増加
• 市場抑制要因分析
  • タンパク質生産に関する規制と安全性への懸念
  • 熟練した人材と専門知識の不足
• 事業環境分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 製品別ビジネス分析

• 研究グレードタンパク質市場：製品の変動分析
• サイトカインと成長因子
  • インターフェロン（IFN）
  • インターロイキン（IL）
  • その他
• 抗体
• 免疫チェックポイントタンパク質
• ウイルス抗原
• 酵素
  • キナーゼ
  • 代謝酵素
  • その他
• 組換え調節タンパク質
• ホルモン
• その他

第5章 宿主細胞別ビジネス分析

• 研究グレードタンパク質市場：宿主細胞の変動分析
• 哺乳類細胞
• 細菌細胞
• 酵母と菌類
• 昆虫細胞
• その他

第6章 最終用途別ビジネス分析

• 研究グレードタンパク質市場：最終用途の変動分析
• 製薬およびバイオテクノロジー企業
• 学術研究機関
• その他

第7章 地域別ビジネス分析

• 地域市場のスナップショット
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業の分類
• 戦略マッピング
• 企業の市場シェア/地位分析、2022年
• 企業プロファイル・一覧表
  • Thermo Fisher Scientific, Inc.
  • Abcam Plc
  • Miltenyi Biotec
  • GenScript
  • Bio-Techne
  • Proteintech Group, Inc.
  • ACROBiosystems
  • Sino Biological, Inc.
  • Prospec-Tany Technogene Ltd.
  • New England Biolabs

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
• Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 6 North America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 9 U.S research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 12 Canada research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 13 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
• Table 14 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 15 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 16 Europe research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 17 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 18 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 19 UK research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 21 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 22 Germany research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 23 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 24 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 25 France research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 26 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 27 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 28 Italy research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 30 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 31 Spain research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 32 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 33 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 34 Denmark research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 35 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 36 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 37 Sweden research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 38 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 39 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 40 Norway research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 45 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 46 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 47 China research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 49 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 50 Japan research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 51 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 52 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 53 India research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 54 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 55 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 56 South Korea research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 58 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 59 Australia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 60 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 61 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 62 Thailand research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 63 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
• Table 64 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 65 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 66 Latin America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 67 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 68 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 69 Brazil research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 70 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 71 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 72 Mexico research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 75 Argentina research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
• Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 82 South Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 88 UAE research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
• Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
• Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
• Table 91 Kuwait research-grade proteins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Market summary
• Fig. 4 Market segmentation & scope
• Fig. 5 Market size and growth prospects
• Fig. 6 Global research-grade proteins market- Key market driver analysis
• Fig. 7 Global research-grade proteins market - Key market restraint analysis
• Fig. 8 Global research-grade proteins market - Porter's analysis
• Fig. 9 Global research-grade proteins market - PESTEL analysis
• Fig. 10 Global research-grade proteins market: Product outlook key takeaways
• Fig. 11 Global research-grade proteins market: Product movement analysis
• Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
• Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
• Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
• Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
• Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
• Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
• Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
• Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
• Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
• Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
• Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
• Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
• Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
• Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
• Fig. 27 Global research-grade proteins market: Host cells movement analysis
• Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
• Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
• Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
• Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
• Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
• Fig. 33 Global research-grade proteins market: End-use outlook key takeaways
• Fig. 34 Global research-grade proteins market: End-use movement analysis
• Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
• Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
• Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
• Fig. 38 Regional marketplace: Key takeaways
• Fig. 39 Global research-grade proteins market: Regional movement analysis
• Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 43 Europe research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 44 UK research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 45 Germany research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 46 France research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 47 Spain research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 48 Italy research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 49 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 50 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 51 Norway research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 52 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 53 Japan research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 54 China research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 55 India research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 56 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 57 Australia research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 58 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 59 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 60 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 61 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
• Fig. 68 Strategy framework

Research-grade Proteins Market Growth & Trends:

The global research-grade proteins market size is estimated to reach USD 2.69 billion by 2030, growing at a CAGR of 15.53% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.'s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights:

• Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.36% in 2022 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
• Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2022. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
• Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.35% in 2022. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
• Based on region, North America dominated the market with a revenue share of 44.86% in 2022. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Host Cell Segment
  • 1.2.3. End-use Segment
• 1.3. Research Assumptions
• 1.4. Information Procurement
  • 1.4.1. Primary Research
• 1.5. Information or Data Analysis
• 1.6. Market Formulation & Validation
• 1.7. Market Model
• 1.8. Global Market: CAGR Calculation
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Research-grade Proteins Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Increasing use of recombinant proteins in research activities
  • 3.3.2. Growing research activities for drug discovery and precision medicine
  • 3.3.3. Rising adoption of biologics & biosimilars
• 3.4. Market Restraint Analysis
  • 3.4.1. Regulatory and safety concerns regarding protein production
  • 3.4.2. Dearth of skilled personnel and expertise
• 3.5. Business Environment Analysis
  • 3.5.1. PESTEL Analysis
  • 3.5.2. Porter's Five Forces Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Research-grade Proteins Market: Product Movement Analysis
• 4.2. Cytokines & Growth Factors
  • 4.2.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
  • 4.2.2. Interferons (IFNs)
    • 4.2.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
  • 4.2.3. Interleukins (ILs)
    • 4.2.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
  • 4.2.4. Others
    • 4.2.4.1. Others Market, 2018 - 2030 (USD Million)
• 4.3. Antibodies
  • 4.3.1. Antibodies, 2018 - 2030 (USD Million)
• 4.4. Immune Checkpoint Proteins
  • 4.4.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
• 4.5. Virus Antigens
  • 4.5.1. Virus Antigens Market, 2018 - 2030 (USD Million)
• 4.6. Enzymes
  • 4.6.1. Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6.2. Kinases
    • 4.6.2.1. Kinases Market, 2018 - 2030 (USD Million)
  • 4.6.3. Metabolic Enzymes
    • 4.6.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6.4. Others
    • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
• 4.7. Recombinant Regulatory Proteins
  • 4.7.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
• 4.8. Hormones
  • 4.8.1. Hormones Market, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

• 5.1. Research-grade Proteins Market: Host Cell Movement Analysis
• 5.2. Mammalian Cells
  • 5.2.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
• 5.3. Bacterial Cells
  • 5.3.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
• 5.4. Yeast & Fungi
  • 5.4.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
• 5.5. Insect Cells
  • 5.5.1. Insect Cells Market, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

• 6.1. Research-grade Proteins Market: End-use Movement Analysis
• 6.2. Pharmaceutical & Biotechnology Companies
  • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 6.3. Academic & Research Institutes
  • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 6.4. Others
  • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Regional Market Snapshot
• 7.2. North America
  • 7.2.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Scenario
    • 7.2.2.4. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Scenario
    • 7.2.3.4. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.4. Spain
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Scenario
    • 7.3.4.4. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.5. France
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Scenario
    • 7.3.5.4. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.6. Italy
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Scenario
    • 7.3.6.4. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Regulatory Scenario
    • 7.3.7.4. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Scenario
    • 7.3.8.4. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Scenario
    • 7.3.9.4. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4.7. Australia
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Mexico Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5.4. Argentina
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Scenario
    • 7.6.4.4. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Scenario
    • 7.6.5.4. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Share/Position Analysis, 2022
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific, Inc.
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Abcam Plc
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Miltenyi Biotec
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Product Benchmarking
    • 8.4.3.3. Strategic Initiatives
  • 8.4.4. GenScript
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Bio-Techne
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Proteintech Group, Inc.
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Product Benchmarking
    • 8.4.6.3. Strategic Initiatives
  • 8.4.7. ACROBiosystems
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Product Benchmarking
    • 8.4.7.3. Strategic Initiatives
  • 8.4.8. Sino Biological, Inc.
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Product Benchmarking
    • 8.4.8.3. Strategic Initiatives
  • 8.4.9. Prospec-Tany Technogene Ltd.
    • 8.4.9.1. Company Overview
    • 8.4.9.2. Product Benchmarking
    • 8.4.9.3. Strategic Initiatives
  • 8.4.10. New England Biolabs
    • 8.4.10.1. Company Overview
    • 8.4.10.2. Product Benchmarking
    • 8.4.10.3. Strategic Initiatives